Plasma Very‐Long‐Chain Fatty Acids in X‐Linked Adrenoleukodystrophy: Diagnostic Insights From a Clinical Laboratory Cohort
Journal of Clinical Laboratory Analysis · 2026-07 · 40 (14)
DOI: 10.1002/jcla.70269 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, online erschienen am 17.06.2026. Verfasst von Sergio Molina Blas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Hospital Universitario Príncipe de Asturias, Madrid, Spain. Hauptthemen laut MEDLINE: Adrenoleukodystrophy, Fatty Acids. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Asociación Española para el Estudio de los Errores Congénitos del Metabolismo (AECOM), Albert Einstein College of Medicine, Yeshiva University.
Abstract (Originalsprache)
Background
X‐linked adrenoleukodystrophy (X‐ALD) is a peroxisomal disorder caused by pathogenic variants in the ABCD1 gene, leading to accumulation of very long‐chain fatty acids (VLCFAs). Plasma VLCFA measurement is central to diagnosis, but its value for prognostic stratification remains uncertain. This study explored the association between biochemical profiles, ABCD1 variants, and clinical phenotypes, and assessed the clinical utility of plasma VLCFA levels.
Methods
We performed a retrospective study of 31 genetically confirmed X‐ALD patients from Western Andalusia evaluated between 2005 and 2025. Clinical data, lipid profiles, and VLCFA parameters were analyzed. Patients were stratified by sex, clinical phenotype, genotype, and lipid status. Associations were assessed using Spearman correlation and non‐parametric tests, and ROC curves were used to evaluate discrimination for cerebral ALD (CALD).
Results
Symptomatic patients showed higher C26:0 levels and C26:0/C22:0 ratios than asymptomatic individuals, with the highest values in patients with cerebral involvement. VLCFA levels differed across clinically defined groups, although substantial overlap was observed. Truncating ABCD1 variants were associated with higher C26:0 levels and C26:0/C22:0 ratios, but not with cerebral involvement. ROC analysis showed moderate discrimination for CALD (AUC = 0.84). No significant longitudinal changes in VLCFA levels were observed.
Conclusions
Plasma VLCFA profiling remains essential for X‐ALD diagnosis and shows moderate group‐level associations with clinical phenotypes, particularly in cerebral involvement. However, its utility for individual prognostic stratification is limited, supporting the need for complementary biomarkers such as C26:0‐LPC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Biochemistry, Hospital Universitario Príncipe de Asturias, Madrid, Spain.
- Inherited Metabolic Disorders Unit, Department of Clinical Biochemistry, Hospital Universitario Virgen del Rocío, Seville, Spain.
- Department of Clinical Biochemistry, Clínica Universidad de Navarra, Pamplona, Spain.
- Department of Pediatrics, Hospital Universitario Virgen del Rocío, Seville, Spain.
- Department of Endocrinology, Hospital Universitario Virgen del Rocío, Seville, Spain.
- Asociación Española para el Estudio de los Errores Congénitos del Metabolismo (AECOM), Madrid, Spain.
ORCID-Profile: Sergio Molina Blas, Ana Isabel Álvarez Ríos, Beatriz Muñoz Cabello, Constanza Navarro Moreno, Elena Dios Fuentes, Eva Venegas Moreno, Carmen Delgado Pecellín
Förderung
- Asociación Española para el Estudio de los Errores Congénitos del Metabolismo (AECOM)
- Albert Einstein College of Medicine, Yeshiva University
Zitieren
APA
Blas, S. M., Pujalte, S. P., Álvarez, A. M., Ríos, A. I. Á., Cabello, B. M., Moreno, C. N., Gila, A. L. G., Fuentes, E. D., Moreno, E. V., & Pecellín, C. D. (2026). Plasma Very‐Long‐Chain Fatty Acids in X‐Linked Adrenoleukodystrophy: Diagnostic Insights From a Clinical Laboratory Cohort. Journal of Clinical Laboratory Analysis, 40(14). https://doi.org/10.1002/jcla.70269
Vancouver
Blas SM, Pujalte SP, Álvarez AM, Ríos AIÁ, Cabello BM, Moreno CN, et al. Plasma Very‐Long‐Chain Fatty Acids in X‐Linked Adrenoleukodystrophy: Diagnostic Insights From a Clinical Laboratory Cohort. Journal of Clinical Laboratory Analysis. 2026;40(14). doi:10.1002/jcla.70269
BibTeX
@article{Blas2026,
author = {Blas, Sergio Molina and Pujalte, Sergio Pérez and Álvarez, Ana Moreno and Ríos, Ana Isabel Álvarez and Cabello, Beatriz Muñoz and Moreno, Constanza Navarro and Gila, Ana Lucia Gómez and Fuentes, Elena Dios and Moreno, Eva Venegas and Pecellín, Carmen Delgado},
title = {Plasma Very‐Long‐Chain Fatty Acids in X‐Linked Adrenoleukodystrophy: Diagnostic Insights From a Clinical Laboratory Cohort},
journal = {Journal of Clinical Laboratory Analysis},
year = {2026},
volume = {40},
number = {14},
doi = {10.1002/jcla.70269}
}
EUVIMED